Expanding the Role of External Control Arms: A Strategic Approach to Modern Clinical Research

External control arms (ECAs) are transforming clinical trials by enhancing efficiency, reducing costs, and addressing ethical challenges. By leveraging real-world data (RWD), ECAs can supplement or replace traditional control groups—accelerating the availability of life-changing therapies, particularly in high-need indications. 

This white paper explores the growing role of ECAs in clinical research and how Verana Health’s curated, research-ready datasets are driving regulatory-grade real-world evidence (RWE) generation.

Access a copy of the white paper to learn:

• The Role of ECAs in Rare and Complex Diseases – How ECAs help overcome recruitment challenges and provide meaningful comparative evidence.
• Regulatory Trends and ECA Best Practices – Insights into FDA guidance and the critical factors needed to ensure scientific rigor.
• Verana Health’s Cutting-Edge Approach – How high-quality RWD and AI-powered Qdata^® accelerate study timelines and enhance clinical trial diversity.

Download the white paper to discover how ECAs are shaping the future of clinical research.